Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

TransMedics (TMDX) Shares Issued (2018 - 2026)

TransMedics has reported Shares Issued over the past 8 years, most recently at -$7.4 million for Q4 2025.

For Q4 2025, Shares Issued fell 139.45% year-over-year to -$7.4 million; the TTM value through Dec 2025 reached $3.2 million, down 84.39%, while the annual FY2025 figure was $3.2 million, 84.39% down from the prior year.
Shares Issued for Q4 2025 was -$7.4 million at TransMedics, down from $1.8 million in the prior quarter.
Over five years, Shares Issued peaked at $18.8 million in Q4 2024 and troughed at -$11.1 million in Q3 2024.
A 5-year average of $1.6 million and a median of $384000.0 in 2023 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: skyrocketed 479.29% in 2023 and later crashed 2048.69% in 2024.
Year by year, Shares Issued stood at -$510000.0 in 2021, then plummeted by 168.82% to -$1.4 million in 2022, then skyrocketed by 479.29% to $5.2 million in 2023, then surged by 260.62% to $18.8 million in 2024, then crashed by 139.45% to -$7.4 million in 2025.
Business Quant data shows Shares Issued for TMDX at -$7.4 million in Q4 2025, $1.8 million in Q3 2025, and $7.1 million in Q2 2025.